Dr Nathalie MAUBON

With 15 years of experience in the pharmaceutical research (public research, pharmaceutical industry in Fournier, Solvay and Abbott labs and biotechnology company), Nathalie MAUBON is a specialist in the development and automation of robust models for high-throughput screening (HCS , HTS , ADMET). She moved several positions managing projects to general direction, via managing teams and services.
Today she has decided to combine the expertise of researchers from the public on the mechanism of a disease, with the researchers from industry in automation and high throughput screening, by creating HCS Pharma, a biotechnology company specialised in development of phenotypic screening using High Content Screening technology (http://www.hcs-pharma.com).